Understanding the complex interplay between PI3K and Wnt signaling in breast cancer will elucidate novel mechanisms of crosstalk and determine whether Wnt-targeted therapeutics will play a future role in breast cancer treatment. The gene discussed is PIK3CD; the disease is breast carcinoma.